Stock Research for ICAD


Featured Broker: Ally Invest

Get the due diligence for another stock.


ICAD Stock Chart & Research Data

The ICAD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ICAD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ICAD Due diligence Resources & Stock Charts

The ICAD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ICAD Detailed Price Forecast - CNN Money CNN View ICAD Detailed Summary - Google Finance
Yahoo View ICAD Detailed Summary - Yahoo! Finance Zacks View ICAD Stock Research & Analysis -

Stock Analysis

TradeIdeas View ICAD Trends & Analysis - Trade-Ideas Barrons View ICAD Major Holders - Barrons
NASDAQ View ICAD Call Transcripts - NASDAQ Seeking View ICAD Breaking News & Analysis - Seeking Alpha
Spotlight View ICAD Annual Report - OTC Report View ICAD OTC Short Report -
TradeKing View ICAD Fundamentals - TradeKing Charts View ICAD SEC Filings - Bar Chart
WSJ View Historical Prices for ICAD - The WSJ Morningstar View Performance/Total Return for ICAD - Morningstar
MarketWatch View the Analyst Estimates for ICAD - MarketWatch CNBC View the Earnings History for ICAD - CNBC
StockMarketWatch View the ICAD Earnings - StockMarketWatch MacroAxis View ICAD Buy or Sell Recommendations - MacroAxis
Bullish View the ICAD Bullish Patterns - American Bulls Short Pains View ICAD Short Pain Metrics -

Social Media Mentions

StockTwits View ICAD Stock Mentions - StockTwits PennyStocks View ICAD Stock Mentions - PennyStockTweets
Twitter View ICAD Stock Mentions - Twitter Invest Hub View ICAD Investment Forum News - Investor Hub
Yahoo View ICAD Stock Mentions - Yahoo! Message Board Seeking Alpha View ICAD Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ICAD - Insider Cow View Insider Transactions for ICAD - Insider Cow
CNBC View ICAD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ICAD - OTC Markets
Yahoo View Insider Transactions for ICAD - Yahoo! Finance NASDAQ View Institutional Holdings for ICAD - NASDAQ

Stock Charts

FinViz View ICAD Stock Insight & Charts - StockCharts View ICAD Investment Charts -
BarChart View ICAD Stock Overview & Charts - BarChart Trading View View ICAD User Generated Charts - Trading View

Latest Financial News for ICAD

ICAD: Q1 2018 Results: Detection Disappointing But Still Looking For 2.0-Related Inflection in 2H
Posted on Tuesday May 22, 2018

While Therapy revenue was just about dead-on with what we had been expecting, Detection revenue was quite disappointing. Detection revenue was 15% lower than where we thought it would come in, with almost all of the miss related to product sales. While we had anticipated Detection revenue would contract sequentially given some lumpiness in Q4 ’17, we did think tomo-related momentum would result in solid double-digit yoy growth in product sales in that segment.

Edited Transcript of ICAD earnings conference call or presentation 14-May-18 8:30pm GMT
Posted on Monday May 21, 2018

Q1 2018 ICAD Inc Earnings Call

Icad: 1Q Earnings Snapshot
Posted on Monday May 14, 2018

The Nashua, New Hampshire-based company said it had a loss of 20 cents per share. Losses, adjusted for severance costs and non-recurring costs, were 19 cents per share. The imaging and early cancer detection ...

iCAD Reports First Quarter 2018 Financial Results
Posted on Monday May 14, 2018

Company Expects to Submit PowerLook Tomo Detection Version 2.0 for FDA Approval Shortly Submission to be Based on Promising Results from Pivotal Clinical Reader Study. Conference call today at 4:30 p.m. ...

Enter a stock symbol to view the stock details.